Subsidy Information and Financing Scheme MSHLFlutamide Tablet 250 mg Flutamide in combination with luteinising hormone-releasing hormone (LHRH) agonists for previously ... See all × MSHLFlutamide Tablet 250 mg Flutamide in combination with luteinising hormone-releasing hormone (LHRH) agonists for previously untreated advanced prostatic carcinoma.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet 250 mg National Cancer Centre National University Hospital